Who to call at Predictive Oncology Inc., and when
Fundz watches for the moments Predictive Oncology Inc. starts buying, and tells you who to reach.
- An alert the day Predictive Oncology Inc. raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Predictive Oncology Inc., from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Predictive Oncology Inc.. With Fundz connected, it knows.
Predictive Oncology Inc.
A senior executive or director joined, left, or changed roles. An 8-K is the notice a US public company must file within four business days of a major event.
precisiontherapeutics.comAI Executive Summary
AI-powered analysis of 8-K filing content
Predictive Oncology's 2025 annual meeting on November 25, 2025 approved a 1,000,000-share increase to the 2024 Equity Incentive Plan, re-elected two Class I directors, ratified KPMG LLP as auditor, and approved issuing 14,903,393 shares on exercise of pre-funded warrants. The warrant approval is the most significant item because it could add substantial dilution relative to the 3,501,430 shares entitled to vote.
Key Takeaways
Stockholders approved an amendment increasing shares available under the 2024 Equity Incentive Plan by 1,000,000 shares, which expands the company's capacity for equity compensation.
Stockholders approved issuing 14,903,393 shares of common stock on exercise of pre-funded warrants, a figure about four times the 3,501,430 shares entitled to vote at the record date.
3 more takeaways
Related Filings (18)
18 more filings from Predictive Oncology Inc. in the last 90 days
Filing Overview
What This Means
Predictive Oncology Inc. filed with the SEC. Fundz turns 8-K material events into an alert with the right executive attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
4 screens from a live account. No signup.